Ona Therapeutics
Ona Therapeutics is focused on the discovery and development of therapeutic biologics to treat metastatic cancer.
Ona Therapeutics has raised €104M across 2 funding rounds from 10 investors, most recently a Series B round in Jun 2026. Based in Barcelona, Spain; founded 2019; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€104M
€104,398,625
Funding rounds
2
Investors
10
distinct backers
Active since
2020-06
latest 2026-06
Funding by year
EUR raised per year · 2026 YTDOna Therapeutics — funding by year — interactive chart.
Data table
| Ona Therapeutics — funding by year | |
|---|---|
| 2020 | €30M |
| 2026 | €74M |
Signals
High confidenceRaise-next likelihood35
base rate 48% for Series B
- ▼ Raised very recently
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood21
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▲ 7y since founding (typical exit age)
- ▲ Recently backed by strong-exit-track investors
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-06-04 | Series B | €74M | Alta Life Sciences,Asabys Partners,Bpifrance,CDTI,COFIDES,Columbus Venture Partners+4 more | View deal → |
| 2020-06-16 | Series A | €30M | — | View deal → |
Investors
10Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Jobandtalent€1.4BSpain · HRtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Perk (formerly TravelPerk)€1.1BSpain · Travel
Global coverage: FundingData